Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Deborah Jean Lee Wong is active.

Publication


Featured researches published by Deborah Jean Lee Wong.


Annals of Oncology | 2017

1316PEfficacy and immune activation with PEGylated human IL-10 (AM0010) in combination with an anti-PD1 in advanced NSCLC: Update

Deborah Jean Lee Wong; Jeffrey Gary Schneider; Raid Aljumaily; Michael Korn; Karen A. Autio; Jeffrey R. Infante; Manish R. Patel; Kyriakos P. Papadopoulos; Aung Naing; Nashat Y. Gabrail; Pamela N. Munster; Jonathan W. Goldman; P. Van Vlasselaer; Annie Hung; Gail Linda Brown; Martin Oft; Edward B. Garon

At therapeutic concentrations, AM0010 stimulates the cytotoxicity, survival and proliferation of intratumoral antigen activated CD8+ T cells in pre-clinical cancer models and in patients. AM0010 activates antigen stimulated CD8 T cells while PD-1 inhibits them. This provides the rationale for combining AM0010 and an anti-PD1. AM0010 monotherapy induced durable objective responses in ocular melanoma and renal cell cancer. AM0010 alone or in combination with chemotherapy and anti-PD1 has been well tolerated in this Phase 1 basket trial. Efficacy and Immune Activation with PEGylated human IL-10 (AM0010) in Combination with an anti-PD1 in Advanced NSCLC Update


European Journal of Cancer | 2015

3090 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with metastatic or recurrent non-small-cell lung cancer progressing after platinum-based chemotherapy: A phase Ib trial

James L. Gulley; Arun Rajan; David R. Spigel; Nicholas Iannotti; Jason Claud Chandler; Deborah Jean Lee Wong; Joseph Leach; William Jeffery Edenfield; Ding Wang; Marcis Bajars; A. Von Heydebreck; Karen Kelly


Journal of Clinical Oncology | 2016

Avelumab (MSB0010718C; anti-PD-L1) in patients with advanced cancer: Safety data from 1300 patients enrolled in the phase 1b JAVELIN Solid Tumor trial.

Karen Kelly; Christopher R. Heery; Manish R. Patel; Jeffrey R. Infante; Nicholas Iannotti; Joseph W. Leach; Ding Wang; Jason Claud Chandler; Hendrik-Tobias Arkenau; Matthew H. Taylor; Michael S. Gordon; Deborah Jean Lee Wong; Howard Safran; Howard L. Kaufman; Ulrich Keilholz; Marcis Bajars; Anja von Heydebreck; Isabell Speit; Jean-Marie Cuillerot; James L. Gulley


Journal of Clinical Oncology | 2016

Pembrolizumab (pembro) plus ipilimumab (ipi) or pegylated interferon alfa-2b (PEG-IFN) for advanced melanoma or renal cell carcinoma (RCC).

Michael B. Atkins; F. Stephen Hodi; John A. Thompson; David F. McDermott; Wen-Jen Hwu; Donald P. Lawrence; Nancy A. Dawson; Deborah Jean Lee Wong; Shailender Bhatia; Marihella James; Xinxin Shu; Rodolfo F. Perini; Nageatte Ibrahim; Antoni Ribas; Toni K. Choueiri


Journal of Clinical Oncology | 2016

Avelumab (MSB0010718C; anti-PD-L1) in patients with advanced adrenocortical carcinoma from the JAVELIN solid tumor phase Ib trial: Safety and clinical activity.

Christophe Le Tourneau; Christopher J. Hoimes; Corrine Zarwan; Deborah Jean Lee Wong; Sebastian Bauer; Martin Wermke; Rainer Claus; Kevin M. Chin; Anja von Heydebreck; Jean-Marie Cuillerot; James L. Gulley


Journal of Clinical Oncology | 2016

Clinical activity and safety of pegylated human IL-10 (AM0010) in combination with anti-PD1.

Aung Naing; Kyriakos P. Papadopoulos; Jeffrey R. Infante; Deborah Jean Lee Wong; Karen A. Autio; Patrick A. Ott; Gerald S. Falchook; Manish R. Patel; Shubham Pant; Amita Patnaik; John B. Mumm; Melinda Whiteside; Ivan H. Chan; Johanna C. Bendell; Todd Michael Bauer; Filip Janku; Rivka R. Colen; Nizar M. Tannir; Peter Van Vlasselaer; Martin Oft


Journal of Clinical Oncology | 2016

Anti-tumor activity of PEGylated human IL-10 (AM0010) in patients with pancreatic or colorectal cancer.

Kyriakos P. Papadopoulos; Aung Naing; Jeffrey R. Infante; Karen A. Autio; Patrick A. Ott; Deborah Jean Lee Wong; Gerald S. Falchook; Manish R. Patel; Shubham Pant; Melinda Whiteside; John B. Mumm; Ivan H. Chan; Johanna C. Bendell; Drew W. Rasco; Kent C. Shih; Milind Javle; Todd Michael Bauer; Rivka R. Colen; Peter Van Vlasselaer; Martin Oft


Journal of Thoracic Oncology | 2018

MA04.02 Responses and Durability in NSCLC Treated With Pegilodecakin and Anti-PD-1

Edward B. Garon; Deborah Jean Lee Wong; Jeffrey Gary Schneider; Raid Aljumaily; Wolfgang Michael Korn; Jeffrey R. Infante; Manish R. Patel; Karen A. Autio; Kyriakos P. Papadopoulos; Aung Naing; Nashat Y. Gabrail; Pamela N. Munster; Jonathan W. Goldman; Annie Hung; P. Van Vlasselaer; Joseph Leveque; Martin Oft; David R. Spigel


Annals of Oncology | 2017

874PImmune correlates for the efficacy of PEGylated Human IL-10 (AM0010) with nivolumab in renal cell cancer

Aung Naing; Jeffrey R. Infante; Deborah Jean Lee Wong; Michael Korn; Raid Aljumaily; Kyriakos P. Papadopoulos; Karen A. Autio; Shubham Pant; Todd Michael Bauer; Alexandra Drakaki; Naval Daver; Annie Hung; P. Van Vlasselaer; Gail Linda Brown; Martin Oft; Nizar M. Tannir


Annals of Oncology | 2017

744POverall survival and immunologic responses in metastatic pancreatic adenocarcinoma (PDAC) on PEGylated human IL-10 (AM0010) with 5-FU/LV and oxaliplatin (FOLFOX)

J.R. Hecht; Aung Naing; Gerald S. Falchook; Manish R. Patel; Jeffrey R. Infante; Raid Aljumaily; Deborah Jean Lee Wong; Karen A. Autio; Zev A. Wainberg; Milind Javle; Johanna C. Bendell; Shubham Pant; Annie Hung; P. Van Vlasselaer; Gail Linda Brown; Martin Oft; Kyriakos P. Papadopoulos

Collaboration


Dive into the Deborah Jean Lee Wong's collaboration.

Top Co-Authors

Avatar

Jeffrey R. Infante

Sarah Cannon Research Institute

View shared research outputs
Top Co-Authors

Avatar

Aung Naing

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Karen A. Autio

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shubham Pant

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gerald S. Falchook

Sarah Cannon Research Institute

View shared research outputs
Researchain Logo
Decentralizing Knowledge